Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Radioactive Holmium Microspheres for the Treatment of Liver Metastases (HEPAR)

This study has been completed.
Information provided by (Responsible Party):
B.A. Zonnenberg, UMC Utrecht Identifier:
First received: December 14, 2009
Last updated: January 30, 2012
Last verified: January 2012